The phosphorylation curve shows that the mTOR pathway is activated by the disrupted function of the TSC1/2 complex, which proves that the carcinogenic lineage of PEComa is a unique TSC2-related tumor (19). The gene discussed is TSC2; the disease is neoplasm with perivascular epithelioid cell differentiation.